Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples